How to Value a Startup: Methods, Math, and What Investors Actually Use

Most founders treat startup valuation like a math problem. Investors treat it like a negotiation. The gap between those two worldviews is where most fundraising falls apart.

You do not have a “real” valuation until an investor writes a check at a number you both agreed on. There is no formula, no certified appraiser, no objective standard that determines what your pre-revenue startup is worth. There are methods — several of them — and understanding how investors apply each one will make you a dramatically better negotiator the next time you sit across a term sheet.

Key takeaways

• Startup valuation is a negotiation, not a calculation — no formula applies universally, especially at the earliest stages.
• Investors use four to five distinct valuation methods depending on your stage; knowing which one applies to you changes how you present your company.
• Pre-money valuation is what your company is worth before new investment closes; post-money valuation is that number plus the check being written.
• The size of your round directly anchors your valuation — raise too little and you signal low ambition; raise too much and you set milestones that bury you.
• A 409A valuation (for employee stock options) is a separate, IRS-driven number that almost always differs significantly from your negotiated round valuation.

What is startup valuation? The direct answer

Startup valuation is the agreed-upon dollar figure that determines how much of your company an investor receives in exchange for their capital. At the early stage, it reflects expected future value rather than current fundamentals — because most startups have no meaningful revenue or assets to anchor a traditional appraisal. The core formula: Post-money valuation = Pre-money valuation + Investment amount. An investor’s ownership stake = Investment ÷ Post-money valuation. Everything else is negotiation.

Why early-stage startup valuation is different from everything you learned in finance class

Public company valuations are derived from earnings, cash flow, and comparable market multiples. Those anchors don’t exist for most early-stage startups.

A seed-stage company with $0 in revenue and a six-month-old product has no earnings to discount. No revenue stream to apply a multiple to. What it has is a team, a market hypothesis, some early user signals, and — most importantly — a story about what it could become.

That’s why startup valuation at the early stage is fundamentally forward-looking. Investors are pricing expected outcomes, not current performance. And expected outcomes are, almost by definition, arguable.

There is no “correct” early-stage valuation. There is only the number an informed investor is willing to pay and an informed founder is willing to accept.

This is why founder expectations and investor anchors often diverge by 2x or 3x on a first call. The investor has seen 50 companies at a similar stage. The founder has seen one.

Startup valuation methods investors actually use

Different stages call for different frameworks. Here is what is actually happening when an investor puts a number on your company.

The Berkus Method (pre-revenue)

Developed by angel investor Dave Berkus, this method assigns value to five key risk-reducers at the earliest stage — before any revenue exists. Each element can add up to $500K in value, for a maximum pre-money valuation of $2.5M.

It is blunt, but it gives pre-revenue founders something to anchor to. If you have a working prototype and two seasoned co-founders but no partnerships and no sales, a reasonable Berkus valuation lands around $1M–$1.5M pre-money.

The Scorecard Method (pre-seed to seed)

The Scorecard Method compares your startup against the median pre-money valuation for similar early-stage companies in your region and sector, then adjusts up or down based on weighted factors.

Typical factor weights:

• Strength of the management team: 0–30%
• Size of the opportunity: 0–25%
• Product or technology: 0–15%
• Competitive environment: 0–10%
• Marketing, sales channels, partnerships: 0–10%
• Need for additional investment: 0–5%

If the regional median pre-revenue seed valuation is $3M and your team scores 1.25x on management and 1.10x on market size, your adjusted valuation comes out around $3.5M–$4M pre-money. The method is only as good as the comparable data — which is why investors with deep deal flow win this argument.

Comparable transactions (seed to Series A)

Once you have any revenue, investors start looking at what similar companies raised at. Not public company multiples — those are almost irrelevant at your stage — but recent funding rounds in your sector at a similar revenue level.

If B2B SaaS companies with $50K MRR are raising Seed rounds at $6M–$10M pre-money valuations and you have $45K MRR with better retention, you have a real comparable anchor. The problem: these comps are sparse, often undisclosed, and dated fast. A good investor will have more data than you. Know your sector’s recent deal comps before you walk into any room.

The VC Method (the most commonly used framework)

This is the dominant framework for institutional investors at seed and Series A. The logic works backwards from exit.

Step 1. Estimate the company’s terminal value at exit (typically 5–7 years out).

Step 2. Apply a target return multiple — typically 10–30x for seed investors, 5–10x for Series A.

Step 3. Divide terminal value by target return to get the post-money valuation today.

Step 4. Subtract the investment to get implied pre-money valuation.

Worked example:

You are raising a $2M Seed round. Your lead investor believes the company could exit at $200M in six years and needs a 20x return on seed bets.

• Implied post-money valuation: $200M ÷ 20 = $10M post-money
• Investor ownership: $2M ÷ $10M = 20%
• Implied pre-money: $10M − $2M = $8M pre-money

Change one assumption — say the investor believes the exit could reach $300M — and the implied pre-money jumps to $13M. The assumptions are everything. Two investors with different exit views will arrive at radically different valuations for the exact same company. That is the negotiation.

DCF (Discounted Cash Flow — appears later, rarely early)

Traditional DCF analysis — projecting future cash flows and discounting back to present value — is the gold standard in corporate finance. For early-stage startups, it is nearly useless.

Why? Because the inputs (projected revenue, margins, growth rates) are too speculative at the seed stage to produce outputs you can defend with a straight face. A DCF model built on five-year projections from a pre-revenue company is, charitably, a sophisticated guess.

DCF becomes meaningful at Series B and beyond, when companies have 18–24 months of revenue data, clear unit economics, and defensible growth trajectories. Before that, it decorates decks more than it drives decisions.

Pre-money vs post-money valuation: the distinction founders miss

These two numbers appear in every term sheet. Confusing them is one of the most common and most expensive founder mistakes.

If an investor offers a $10M pre-money valuation on a $2M raise:

• Post-money = $10M + $2M = $12M
• Investor ownership = $2M ÷ $12M = 16.7%
• You retain: 83.3%

If they offer a $10M post-money valuation on the same $2M raise:

• Pre-money = $10M − $2M = $8M
• Investor ownership = $2M ÷ $10M = 20%
• You retain: 80%

Same words. Three extra percentage points of your company gone. Over multiple rounds, that gap compounds.

Always establish pre-money or post-money before any other valuation conversation. It is the first question, every time.

Most SAFE notes today use a post-money cap, which means the investor’s ownership is fully calculable the moment you sign. If you issued $1.5M in SAFEs at a $8M post-money cap, that investor already owns 18.75% of your company — before you raise a priced round. Model this before you negotiate the Seed.

How round size sets your startup valuation

This is the part most founders do not model until after they have already sent the pitch deck.

Your round size and your valuation are not independent variables. They are linked through investor ownership targets.

Most seed-stage institutional investors target 10–20% ownership per investment. If a fund is writing a $2M check and targeting 15% ownership, they need a post-money valuation of $2M ÷ 0.15 = $13.3M. If you raise $3M instead, the implied post-money rises to $20M. If your traction does not support a $17M pre-money valuation, you will either negotiate down on check size, give up more ownership, or lose the deal.

Raise what you genuinely need to hit a specific, clear milestone — typically 18–24 months of runway — and let the valuation follow from the math. The round size you announce signals your ambition and your model. Too small signals you are not thinking big enough. Too large at an unsupportable valuation means your next milestones are already underwater.

409A valuation vs negotiated round valuation: not the same number

This distinction causes real legal and equity problems when founders conflate them.

A 409A valuation is an independent appraisal of your company’s fair market value for common stock, required by the IRS whenever you issue stock options to employees. It determines the strike price on those options. It must be performed by a qualified, independent appraiser — typically annually or within 12 months of each financing round.

Your negotiated VC valuation and your 409A are almost always different. They are supposed to be.

• VC investors receive preferred stock with liquidation preferences, anti-dilution protections, and other economic rights
• Employees receive options on common stock, which carries less value than preferred
• The IRS requires options be priced at fair market value for common — not the inflated value implied by a preferred round

At the seed stage, a 409A might peg your common stock at 20–40% of your last round’s post-money valuation. This is normal and intentional.

A low 409A is a feature, not a bug. It keeps your option pool attractive to the talent you need to hire without giving away equity at inflated preferred-round prices.

Do not skip or delay the 409A. Issuing options below fair market value creates IRS penalties for employees — a serious legal problem that will surface during any future due diligence process.

What raises and lowers your startup valuation in practice

When you are negotiating, these are the real levers.

Factors that push valuation up:

• A strong founding team with prior exits or deep, demonstrable domain expertise
• Large, clear, and growing market with a TAM that holds up to scrutiny
• Revenue traction with strong retention — NRR above 100% is a compelling signal
• Network effects or competitive moats beginning to emerge
• Competitive term sheet dynamics — multiple offers change every conversation
• Strategic investors whose names on your cap table carry signal value

Factors that push valuation down:

• Solo founder, or founding team with obvious capability gaps
• No revenue or very limited early validation
• Highly competitive market with no clear differentiation
• Existing investors who are not re-investing in the current round — this is a serious red flag that sophisticated new investors will probe
• Long fundraising timelines, which signal weak market reception
• An over-diluted cap table from prior rounds that leaves little room for future investors

The lever most founders underestimate: optionality. An investor who believes this company could become a $1B outcome will price it very differently than one who sees a $50M ceiling. Your job in the fundraising process is not just to explain what you have built — it is to make the large outcome feel not just possible but probable.

Find the right investors for your stage

Knowing your valuation is only half the equation. Getting in front of the right investors — ones who actively invest at your stage, in your sector, at the check size your round requires — is the other half.

VC Match by Innovent Capital connects early-stage founders with vetted venture investors who are actively deploying capital in your space. Stop cold-emailing the wrong funds. Start pitching investors who are already looking for what you are building.

FAQ

How do you value a startup with no revenue?

At the pre-revenue stage, investors rely on qualitative frameworks like the Berkus Method or the Scorecard Method. These assess the founding team, market size, prototype quality, and early partnerships to assign value — typically in the $1M–$5M pre-money range for early-stage companies in the US, though this varies widely by sector, location, and market conditions at the time of the raise.

What is a good valuation for a seed-stage startup?

There is no universal benchmark, but US seed valuations typically range from $5M to $15M pre-money for companies with early traction. Pre-revenue companies often see $1M–$5M pre-money. The right valuation is one that lets you raise the capital you need to hit your next clear milestone while leaving enough ownership dilution headroom for future rounds and key hires.

What is the difference between pre-money and post-money valuation?

Pre-money is your company’s agreed value immediately before new investment closes. Post-money = pre-money + the investment amount. Investor ownership is always calculated as Investment ÷ Post-money valuation. A $10M pre-money vs $10M post-money offer on a $2M round translates to 16.7% vs 20% investor ownership — nearly four percentage points of your company on a single term.

How does the size of my round affect my startup valuation?

They are directly linked through investor ownership targets. If an investor targets 15% ownership and is writing a $2M check, they need a $13.3M post-money valuation. If you raise $3M instead, the implied post-money rises to ~$20M. Build your round size from genuine capital needs and a specific milestone, then confirm the implied valuation is defensible given your traction and sector comps.

When do I need a 409A valuation, and how is it different from my funding round valuation?

You need a 409A valuation whenever you issue stock options to employees, and it must be refreshed at least annually and after each priced equity round. Unlike your negotiated round valuation — which reflects the price of preferred stock — a 409A appraises the fair market value of your common stock. The 409A will typically be significantly lower than your preferred round valuation, which is both legally required and beneficial for your employees’ option economics.

Final Thought

Valuation is the number everyone fixates on and, in the long run, the number that matters least.

What matters is whether you raised enough capital to hit your next milestone. Whether the ownership you kept is meaningful. Whether the investors across the table will actively help you build. A brilliant valuation on a dead company is worth nothing. A “low” valuation on a company that compounds to $500M makes everyone rich.

Know the methods. Understand the math. And then focus on building something investors cannot afford to miss.